Detailed description page of ThPDB2
| This page displays user query in tabular form. |
Th1602 details |
| Primary information | |
|---|---|
| ID | 15494 |
| Therapeutic ID | Th1602 |
| Protein Name | Albumin Aggregated |
| Sequence | NA |
| Molecular Weight | NA |
| Chemical Formula | NA |
| Isoelectric Point | NA |
| Hydrophobicity | NA |
| Melting point | NA |
| Half-life | NA |
| Description | Albumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection.[L12816] This imaging agent is used to assess lung perfusion and for the evaluation of peritoneovenous (LeVeen) shunt patency. |
| Indication/Disease | Albumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection, which is indicated for the assessment of lung perfusion and for the evaluation of peritoneovenous (LeVeen) shunt patency.[L12816] |
| Pharmacodynamics | NA |
| Mechanism of Action | NA |
| Toxicity | NA |
| Metabolism | NA |
| Absorption | NA |
| NA | |
| Clearance | NA |
| Categories | Radioactive Diagnostic Agent |
| Patents Number | NA |
| Date of Issue | NA |
| Date of Expiry | NA |
| Drug Interaction | NA |
| Target | NA |
| Brand Name | Draximage Maa |
| Company | Jubilant DraxImage Inc., dba Jubilant Radiopharma |
| Brand Description | Jubilant DraxImage Inc., dba Jubilant Radiopharma |
| Prescribed For | Intravenous |
| Chemical Name | 2.5 mg/1 |
| Formulation | NA |
| Physical Appearance | Instances of hemodynamic or idiosyncratic reactions to preparations of Technetium Tc 99m Albumin Aggregated have been reported |
| Route of Administration | The kit consists of reaction vials which contain the sterile, non-pyrogenic, non-radioactive ingredients necessary to produce Technetium Tc 99m Albumin Aggregated Injection for diagnostic use by intravenous injection. |
| Recommended Dosage | Technetium Tc 99m Albumin Aggregated Injection is a lung imaging agent which may be used as an adjunct in the evaluation of pulmonary perfusion in adults and pediatric patients. |
| Contraindication | NA |
| Side Effects | NA |
| Useful Link 1 | Link |
| Useful Link 2 | Link |
| Remarks | NA |
| Primary information | |
|---|---|
| ID | 15495 |
| Therapeutic ID | Th1602 |
| Protein Name | Albumin Aggregated |
| Sequence | NA |
| Molecular Weight | NA |
| Chemical Formula | NA |
| Isoelectric Point | NA |
| Hydrophobicity | NA |
| Melting point | NA |
| Half-life | NA |
| Description | Albumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection.[L12816] This imaging agent is used to assess lung perfusion and for the evaluation of peritoneovenous (LeVeen) shunt patency. |
| Indication/Disease | Albumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection, which is indicated for the assessment of lung perfusion and for the evaluation of peritoneovenous (LeVeen) shunt patency.[L12816] |
| Pharmacodynamics | NA |
| Mechanism of Action | NA |
| Toxicity | NA |
| Metabolism | NA |
| Absorption | NA |
| NA | |
| Clearance | NA |
| Categories | NA |
| Patents Number | NA |
| Date of Issue | NA |
| Date of Expiry | NA |
| Drug Interaction | NA |
| Target | NA |
| Brand Name | Macrotec |
| Company | Bracco Diagnostics, Inc |
| Brand Description | Bracco Diagnostics, Inc |
| Prescribed For | Intravenous |
| Chemical Name | NA |
| Formulation | NA |
| Physical Appearance | Although adverse reactions specifically attributable to the Technetium Tc 99m Albumin Aggregated Injection have not been noted, the literature contains reports of deaths occurring after the administration of Albumin Aggregated to patients with pre-existing severe pulmonary hypertension. Instances of hemodynamic or idiosyncratic reactions topreparations of Technetium Tc 99m Albumin Aggregated have been reported. |
| Route of Administration | Macrotec is a sterile, nonpyrogenic, Iyophilized preparation of albumin aggregated. Each 5 mL vial of Macrotec contains 1.5 mg of Albumin Aggregated, 10.0 mg Albumin Human, 0.07 mg (minimum) stannous chloride (SnCl2•2H2O) and 0.19 mg total tin, maximum (as stannous chloride, SnCl2•2H2O), 1.8 mg of sodium chloride with trace amounts of sodium acetate, acetic acid and hydrochloric acid. Macrotec contains no preservatives. The pH of the reconstituted product is between 3.8 and 8.0. |
| Recommended Dosage | Macrotec (Kit for the Preparation of Technetium Tc 99m Albumin Aggregated) is a lung imaging agent which may be used as an adjunct in the evaluation of pulmonary perfusion in adults and children. It is useful in the early detection of pulmonary emboli and in the evaluation of the status of the pulmonary circulation in such conditions as pulmonary neoplasm, pulmonary tuberculosis and emphysema. |
| Contraindication | NA |
| Side Effects | NA |
| Useful Link 1 | Link |
| Useful Link 2 | Link |
| Remarks | NA |
| Primary information | |
|---|---|
| ID | 15496 |
| Therapeutic ID | Th1602 |
| Protein Name | Albumin Aggregated |
| Sequence | NA |
| Molecular Weight | NA |
| Chemical Formula | NA |
| Isoelectric Point | NA |
| Hydrophobicity | NA |
| Melting point | NA |
| Half-life | NA |
| Description | Albumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection.[L12816] This imaging agent is used to assess lung perfusion and for the evaluation of peritoneovenous (LeVeen) shunt patency. |
| Indication/Disease | Albumin aggregated is an ingredient in the DRAXIMAGE MAA kit for the preparation of technetium tc99m albumin aggregated injection, which is indicated for the assessment of lung perfusion and for the evaluation of peritoneovenous (LeVeen) shunt patency.[L12816] |
| Pharmacodynamics | NA |
| Mechanism of Action | NA |
| Toxicity | NA |
| Metabolism | NA |
| Absorption | NA |
| NA | |
| Clearance | NA |
| Categories | NA |
| Patents Number | NA |
| Date of Issue | NA |
| Date of Expiry | NA |
| Drug Interaction | NA |
| Target | NA |
| Brand Name | Pulmotech MAA |
| Company | Curium US LLC |
| Brand Description | Curium US LLC |
| Prescribed For | Intraperitoneal; Intravenous |
| Chemical Name | 2 mg/15mL |
| Formulation | Technetium Tc 99m Albumin Aggregated Injection is contraindicated in patients with:Severe pulmonary hypertension [see ADVERSE REACTIONS].Prior hypersensitivity to products containing human serum albumin [see ADVERSE REACTIONS]. |
| Physical Appearance | deaths in patients with severe pulmonary hypertension and serious hypersensitivity reactions |
| Route of Administration | NA |
| Recommended Dosage | Technetium Tc 99m Albumin Aggregated Injection is a radioactive diagnostic agent indicated for: |
| Contraindication | NA |
| Side Effects | NA |
| Useful Link 1 | Link |
| Useful Link 2 | Link |
| Remarks | NA |